From Novartis, Bristol MS meds to new ADCs, here are 2020’s blockbuster drug launches

From Novartis, Bristol MS meds to new ADCs, here are 2020's blockbuster drug launches

Special Reports The 10 most-anticipated drug launches of 2020

Special Reports The 10 most-anticipated drug launches of 2020

Myeloma cell therapies, now in pharma hands, move into spotlight

Myeloma cell therapies, now in pharma hands, move into spotlight

A Cure for Cancer? How CAR T-Cell Therapy is Revolutionizing Oncology

A Cure for Cancer? How CAR T-Cell Therapy is Revolutionizing Oncology

Move aside, Humira. Merck’s Keytruda will capture industry’s top sales spot in 2024: report

Move aside, Humira. Merck's Keytruda will capture industry's top sales spot in 2024: report

All the ASCO skinny: Lynparza’s pancreatic win, Amgen’s KRAS spotlight, Merck’s history-busting and more

All the ASCO skinny: Lynparza's pancreatic win, Amgen's KRAS spotlight, Merck's history-busting and more